Novartis announces CTL019 data published in NEJM demonstrating efficacy in certain patients with
Novartis International AG / Novartis announces CTL019 data published in NEJM demonstrating efficacy in certain patients with acute lymphoblastic leukemia (ALL) . Processed and transmitted by Nasdaq OMX Corporate Solutions. The …